Your Article Summary
Synchronous colorectal liver metastases: is it time to reconsider traditional paradigms of management
Annals of Surgical Oncology, 06/12/09
Reddy SK et al. - In a review of synchronous colorectal liver metastases (CLM), it appears that the traditional treatment paradigm centering on the utility of prehepatectomy chemotherapy for resectable synchronous CLM should be reconsidered. Recent developments underscore the need for prospective randomized controlled trials evaluating the optimal timing of hepatectomy relative to chemotherapy.
Methods- Pts with synchronous CLM are typically treated with initial colorectal resection followed by arbitrary and prolonged courses of chemotherapy.
- Partial hepatectomy is considered only for pts without interval disease progression.
- This review describes the rationale for this treatment approach and recent developments suggesting that this management paradigm should be reconsidered.
- Because asymptomatic colorectal cancer often does not lead to complications, and given the potential benefit of chemotherapy in downsizing unresectable to resectable liver disease, most pts with asymptomatic primary tumors and unresectable synchronous CLM should be first treated with chemotherapy.
- Initial hepatic resection should be considered for resectable synchronous CLM.
- Survival benefits from prehepatectomy chemotherapy have not been established.
- Several reports demonstrate morbidity after hepatic resection from extended durations of irinotecan- and/or oxaliplatin-based prehepatectomy chemotherapy.
- Although shorter treatment periods may not have these deleterious effects on subsequent hepatic resection, prospective studies reveal that most pts with supposedly aggressive disease with short treatment durations will not be identified.
- Complete radiologic response to prehepatectomy chemotherapy is not only rare but also does not equate with a complete pathological response.
- Several studies suggest that simultaneous colorectal and minor hepatic resections can performed safely with benefits in total morbidity when compared with traditional staged procedures.
Related Articles
Surgical management of colorectal liver metastases
Community Oncology, 10/09/09
Relevance Score: 70%
Influence of Chemotherapy on Liver Regeneration Induced by Portal Vein Embolization or First Hepatectomy of a Staged Procedure for Colorectal Liver Metastases
Journal of Gastrointestinal Surgery, 11/09/09
Relevance Score: 69%
Repeat Curative Intent Liver Surgery is Safe and Effective for Recurrent Colorectal Liver Metastasis: Results from an International Multi-institutional Analysis
Journal of Gastrointestinal Surgery, 10/08/09
Relevance Score: 68%
Peritoneal carcinomatosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection
European Journal of Surgical Oncology, 11/17/09
Relevance Score: 67%
Impact of Preoperative Bevacizumab on Complications After Resection of Colorectal Liver Metastases: Case-Matched Control Study
World Journal of Surgery, 10/21/09
Relevance Score: 67%
Today in Colorectal Cancer/Polyps...keeping you current
Receive free subspecialty "5-minute updates" via email
Proanthocyanidins and the risk of colorectal cancer in Italy
Cancer Causes and Control, 12/17/09
Health and lifestyle behaviors among persons at risk of Lynch syndrome
Cancer Causes and Control, 12/17/09
Distribution of advanced neoplasia according to polyp size at screening colonoscopy
Alimentary Pharmacology and Therapeutics, 12/17/09
Today in GI Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/17/09
Delay in Diagnostic Workup and Treatment of Esophageal Cancer
Journal of Gastrointestinal Surgery, 12/17/09
Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours
Alimentary Pharmacology and Therapeutics, 12/17/09
Today in Hepatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Influenza Vaccination in Liver Transplant Recipients
Transplantation, 12/17/09
Screening for hepatitis B in chemotherapy patients: survey of current oncology practices
Alimentary Pharmacology and Therapeutics, 12/17/09
Spontaneous liver rupture in hypereosinophilic syndrome: A rare but fatal complication
World Journal of Gastroenterology, 12/17/09

See Latest Articles